Anti-cancerous efficacy and pharmacokinetics of 6-mercaptopurine loaded chitosan nanoparticles

被引：32

作者：

Kumar, G. Prem ^{[1
,2
]}

Sanganal, Jagadeesh S. ^{[2
]}

Phani, A. R. ^{[3
]}

Manohara, C. ^{[2
]}

Tripathi, Syamantak M. ^{[4
]}

Raghavendra, H. L. ^{[5
]}

Janardhana, P. B. ^{[6
]}

Amaresha, S. ^{[2
]}

Swamy, K. B. ^{[2
]}

Prasad, R. G. S. V. ^{[7
]}

机构：

[1] Bioneeds India Private Ltd, Dept Toxicol, Bangalore, Karnataka, India

[2] Vet Coll, Dept Vet Pharmacol & Toxicol, Bangalore, Karnataka, India

[3] Nano Res Adv Mat & Technol, Bangalore, Karnataka, India

[4] Coll Vet Sci & Anim Husb, Durg, Chhattisgarh, India

[5] Wollega Univ, Coll Med & Hlth Sci, Sch Med, Nekemte, Ethiopia

[6] Stellixir Biotech Private Ltd, Bangalore, Karnataka, India

[7] Asian Metropolitan Univ, Fac Pharmaceut Sci, Selangor, Kualalumpur, Malaysia

来源：

PHARMACOLOGICAL RESEARCH | 2015年 / 100卷

关键词：

Chitosan nanoparticles; Cytotoxic; Apoptosis; ROS and bioavailability; ACUTE LYMPHOBLASTIC-LEUKEMIA; CELL-CYCLE; IN-VIVO; DRUG; MERCAPTOPURINE; DERIVATIVES; PROGRESSION; ABROGATION; HYDROGELS; DESIGN;

D O I：

10.1016/j.phrs.2015.07.025

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

6-Mercaptopurine is a cytotoxic and immunosuppressant drug. The use of this drug is limited due to its poor bioavailability and short plasma half-life. In order to nullify these drawbacks, 6-mercaptopurine-chitosan nanoparticles (6-MP-CNPs) were prepared and evaluated to study the influence of preparation conditions on the physicochemical properties by using DLS, SEM, XRD and FTIR. The in vitro drug release profile at pH 4.8 and 7.4 revealed sustained release patterns for a period of 2 days. The nanoformulations showed enhanced in vitro anti-cancer activities (MU assay, apoptosis assay, cell cycle arrest and ROS indices) on HT-1080 and MCF-7 cells. In vivo pharmacokinetics profiles of 6-MP-CNPs showed improved bioavailability. Thus, the results of the present study revealed that, the prepared 6-MP-CNPs have a significant role in increasing anti-cancer efficacy, bioavailability and in vivo pharmacokinetics profiles. (C) 2015 Elsevier Ltd. All rights reserved.

引用

页码：47 / 57

页数：11

共 54 条

[1]

AbdElhady MM., 2012, International Journal of Carbohydrate Chemistry, V2012, P1, DOI DOI 10.1155/2012/840591

[2] Recent advances on chitosan-based micro- and nanoparticles in drug delivery [J].

Agnihotri, SA ;

Mallikarjuna, NN ;

Aminabhavi, TM .

JOURNAL OF CONTROLLED RELEASE, 2004, 100 (01) :5-28

[3] 5-Fluorouracil Encapsulated Chitosan Nanoparticles for pH-Stimulated Drug Delivery: Evaluation of Controlled Release Kinetics [J].

Aydin, R. Seda Tigli ;

Pulat, Mehlika .

JOURNAL OF NANOMATERIALS, 2012, 2012

[4] 2′-C-cyano-2′-deoxy-1-β-D-arabino-pentofuranosylcytosine:: A novel anticancer nucleoside analog that causes both DNA strand breaks and G2 arrest [J].

Azuma, A ;

Huang, P ;

Matsuda, A ;

Plunkett, W .

MOLECULAR PHARMACOLOGY, 2001, 59 (04) :725-731

[5] Colloidal drug carriers: achievements and perspectives [J].

Barratt, G .

CELLULAR AND MOLECULAR LIFE SCIENCES, 2003, 60 (01) :21-37

[6] Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications [J].

Berger, J ;

Reist, M ;

Mayer, JM ;

Felt, O ;

Peppas, NA ;

Gurny, R .

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 57 (01) :19-34

[7] Chitosan-based drug delivery systems [J].

Bernkop-Schnuerch, Andreas ;

Duennhaupt, Sarah .

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2012, 81 (03) :463-469

[8] Chitosan-based hydrogels for controlled, localized drug delivery [J].

Bhattarai, Narayan ;

Gunn, Jonathan ;

Zhang, Miqin .

ADVANCED DRUG DELIVERY REVIEWS, 2010, 62 (01) :83-99

[9]

Calvo P, 1997, J APPL POLYM SCI, V63, P125, DOI 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO

[10]

2-4

← 1 2 3 4 5 6 →